Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights (all comparisons are to the prior year period)Worldwide revenue of $56.3 million, representing growth of 15.0% U.S. revenue of $53.5 million, representing growth of 13.9% Gross margin of 79.0% Net loss of $1.6 million, representing an improvement of 63.3% Positive adjusted EBITDA of $5.1 million, representing an improvement of 176.2% Positive cashflow from operations...

Vastned concludes 2025 with a stable EPRA result, a decrease of the debt ratio below 40% and an increase in the proposed dividend. After completion of the reverse cross-border merger, the group operates with one listed entity and simplified governance. Vastned achieves the objectives of the reverse cross-border merger… ✔ An organizational simplification that improves the efficiency of the Vastned group with only one listed entity, one management and simplified governance.✔ An operational synergy worth € 2.0 million, with additional potential in 2026.✔ Optimized debt financing by signing credit refinancing in 2025 for an amount of € 395.0 million. ✔ Increased liquidity with the entry into the Euronext BEL Mid index in 2025. In January 2026, Vastned received the award of 2025 BEL MID Company of the year...

CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) — via IBN — MedWell Ai, Inc, (OTCQB:MWAI) (“Company”) is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness, is pleased to confirm the filing, after the market close, of its Quarterly Report (Form 10-Q), for the financial period, ending on December 31, 2025. The Company reported $548,315 in Revenue for its fiscal second quarter of 2025. This performance was result of a successful strategic shift toward building an AI-driven healthcare, pharmaceutical and biological wellness portfolio.  Key Financial Highlights: Increased Total Revenues:For three months, ended December 31, 2025, Company had generated total revenues of 548,315 vs $142,861 for three months, ended December 31, 2024 (280%+ increase). For...

LAVAL, Quebec, Feb. 23, 2026 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the accessibility industry, announces it will release its financial results for the fourth quarter of 2025 after market closes on March 4, 2026. Savaria’s management will hold an investor conference call and webcast at 8:30 a.m. Eastern Standard Time (EST) on Thursday, March 5, 2026. Investors and members of the media are invited to participate on a listen-only basis. Conference call access: https://register-conf.media-server.com/register/BI11584c57606d4117a7bc686702e48569 To access the conference call, you must register online and choose the method to join the call, either by dialing the number provided to you or by entering your phone number to receive a call from the system. Webcast URL (EN): https://edge.media-server.com/mmc/p/gd2pkz3c About...

Conference Call Today, at 10:00 a.m. Eastern Time Investor Day Scheduled for March 19, 2026, at the new Nashville, TN campus PARSIPPANY, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the fourth quarter and fiscal year ended December 31, 2025, as well as recent business developments. Fourth Quarter 2025 Financial and Operational HighlightsRevenue of $142.9 million, increased $23.5 million, or 19.7%; 21.4% excluding the Transitional segment Net income increased to $12.7 million, or $0.40 per share, compared to $6.8 million, or $0.22 per share last year Adjusted EBITDA of $29.1 million, increased by $9.9 million, or 51.2% Net cash flow from operations of $43.5 million, compared to $30.3 million last year Student starts grew by 15.7%...

Total 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively,representing 65% and 66% year-over-year growth AUVELITY® 4Q and full year 2025 net product sales of $155.1 million and $507.1 million, respectively,representing 68% and 74% year-over-year growth SUNOSI® 4Q and full year 2025 net product revenue of $36.7 million and $124.8 million, respectively,representing 40% and 32% year-over-year growth SYMBRAVO® 4Q and full year 2025 net product sales of $4.1 million and $6.6 million, respectively sNDA for AXS-05 for the treatment of Alzheimer’s disease agitation granted Priority Review with PDUFAtarget action date of April 30, 2026 Acquired AXS-17, a novel oral GABAA α2,3 receptor positive allosteric modulator Company to host conference call today at 8:00 AM Eastern NEW...

Exosens exceeds 2025 guidance, driven by strong Defense momentum in night vision and digital imaging New mid-term outlook: Accelerating our profitable growth path HIGHLIGHTSSustained above-guidance revenue growth of +22.1% to €468.2m in 2025, driven by strong momentum in Defense & Surveillance (accounting for 75% of 2025 revenue)Amplification revenue up +18.4%, fueled by accelerating global demand for image intensifier tubes for night vision applications; capacity expansion plan underway in Europe and the United States, already supporting an increase of 40% by 2027 D&I revenue up +28.0% in 2025, delivering solid LFL1 performance (+5.4%), which strengthened throughout the year and culminated in a particularly strong Q4 (LFL +15.9%), driven by increasing demand for imaging technologies in platform- and drone-based Defense &...

NEWMARKET, Ontario, Feb. 20, 2026 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that it will release its fourth quarter and unaudited full year 2025 results after markets close on March 4, 2026. The release will be followed by a conference call to discuss the results on Thursday, March 5, 2026, at 9:00 am ET. The Company will file its audited annual consolidated financial statements and related management’s discussion and analysis for the year ended December 31, 2025 following the conclusion of the audit and in accordance with applicable securities laws. FOURTH QUARTER AND ANNUAL 2025 FINANCIAL RESULTS CONFERENCE CALL DETAILS:DATE: Thursday, March 5, 2026TIME: 9:00 am ETDIAL-IN NUMBER: 1-800-715-9871 or 1-647-932-3411 – ask to join the AirBoss call or...

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) announced on February 17, 2026 that it would be holding its fourth quarter conference call on March 10, 2026 at 8:00 am. Constellation has changed the date of the conference call to March 9, 2026 at 8:30 am. The Company’s quarterly results will be disseminated via press release, and made available on the Company’s website (www.csisoftware.com) and SEDAR+ (www.sedarplus.ca), at 7:00 am EST on Monday, March 9, 2026. Mark Miller, President, Jamal Baksh, Chief Financial Officer, and Bernard Anzarouth, Chief Investment Officer will be available during the March 9, 2026 conference call to answer questions regarding the Company’s results. To access the call, please dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) and using conference...

RANCHO CUCAMONGA, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”) today reported financial results for the fiscal second quarter ended December 31, 2025. Revenue was $7.1 million, reflecting the Company’s deliberate supply chain restructuring and transition to predominantly U.S.-based sourcing during the quarter, while gross profit was $3.1 million and gross margin remained strong at 44.0%. Total operating expenses declined 28% year-over-year to $5.6 million compared to the quarter ended December 31, 2024. Net loss attributable to iPower was $1.2 million, or $(1.08) per share. The Company reported $2.0 million of cash and cash equivalents, $2.2 million of restricted cash, and approximately $2.2 million of digital assets. During December 2025, the Company implemented a Digital Asset...